Literature DB >> 2206790

Unimodal distribution of the metabolic ratio for debrisoquine in Cuna Amerindians of Panama.

L F Jorge1, T D Arias, T Inaba, P R Jackson.   

Abstract

1. The metabolic oxidation of debrisoquine (DB) was studied in 89 non-related Cuna Amerindian subjects. 2. Means and standard deviations for urinary recoveries of the intact drug and its 4-hydroxy metabolite (4-HD) were: %DB: 6.8 +/- 4.5; %4-HD: 16.0 +/- 9.1; %sum: 22.8 +/- 12.0. The log10 metabolic ratios for DB (LMRDB) were distributed within a single mode of insignificant skewness (-0.01, P greater than 0.10), which was unimodal (log kernel density and maximum likelihood methods) and normal (chi 2 = 22.5; d.f. = 15; P greater than 0.09; power of the test greater than 80%). 3. Therefore, no poor metabolizers (95% C.I.: 0.1%, 5.2%) were detected in the population sample studied.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2206790      PMCID: PMC1368229          DOI: 10.1111/j.1365-2125.1990.tb03776.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  11 in total

1.  Gas-liquid chromatographic electron capture determination of some monosubstituted guanido-containing drugs.

Authors:  P Erdtmansky; T J Goehl
Journal:  Anal Chem       Date:  1975-04       Impact factor: 6.986

2.  An observation on the ethnic uniqueness of the debrisoquine and sparteine antimodes: a study in the Ngawbé Guaymí Amerindians of Panamá.

Authors:  T D Arias; L F Jorge
Journal:  Br J Clin Pharmacol       Date:  1989-10       Impact factor: 4.335

3.  Polymorphic debrisoquin hydroxylation in 757 Swedish subjects.

Authors:  E Steiner; L Bertilsson; J Säwe; I Bertling; F Sjöqvist
Journal:  Clin Pharmacol Ther       Date:  1988-10       Impact factor: 6.875

4.  A preliminary note on the transient polymorphic oxidation of sparteine in the Ngawbé Guaymí Amerindians: a case of genetic divergence with tentative phylogenetic time frame for the pathway.

Authors:  T D Arias; T Inaba; R G Cooke; L F Jorge
Journal:  Clin Pharmacol Ther       Date:  1988-09       Impact factor: 6.875

5.  Polymorphism of the 4-hydroxylation of debrisoquine in the San Bushmen of southern Africa.

Authors:  D K Sommers; J Moncrieff; J Avenant
Journal:  Hum Toxicol       Date:  1988-05

6.  Low frequency of slow debrisoquine hydroxylation in a native Chinese population.

Authors:  Y C Lou; L Ying; L Bertilsson; F Sjöqvist
Journal:  Lancet       Date:  1987-10-10       Impact factor: 79.321

7.  Pharmacoanthropology: drug metabolism.

Authors:  W Kalow
Journal:  Fed Proc       Date:  1984-05-15

8.  Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations.

Authors:  K Nakamura; F Goto; W A Ray; C B McAllister; E Jacqz; G R Wilkinson; R A Branch
Journal:  Clin Pharmacol Ther       Date:  1985-10       Impact factor: 6.875

9.  The oxidative metabolism of sparteine in the Cuna Amerindians of Panama: absence of evidence for deficient metabolizers.

Authors:  T D Arias; L F Jorge; D Lee; R Barrantes; T Inaba
Journal:  Clin Pharmacol Ther       Date:  1988-04       Impact factor: 6.875

10.  Ethnic difference in drug metabolism: debrisoquine 4-hydroxylation in Caucasians and Orientals.

Authors:  W Kalow; S V Otton; D Kadar; L Endrenyi; T Inaba
Journal:  Can J Physiol Pharmacol       Date:  1980-09       Impact factor: 2.273

View more
  1 in total

Review 1.  Pharmacogenetic research activity in Central America and the Caribbean: a systematic review.

Authors:  Carolina Céspedes-Garro; María-Eugenia G Naranjo; Fernanda Rodrigues-Soares; Adrián LLerena; Jorge Duconge; Lazara K Montané-Jaime; Hilda Roblejo; Humberto Fariñas; María de Los A Campos; Ronald Ramírez; Víctor Serrano; Carmen I Villagrán; Eva M Peñas-LLedó
Journal:  Pharmacogenomics       Date:  2016-09-16       Impact factor: 2.533

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.